| Benjamin F Lagrone, MD | |
|
405 Londonderry Dr, Suite 105, Waco, TX 76712-7924 | |
| (254) 776-0266 | |
| (254) 776-2511 |
| Full Name | Benjamin F Lagrone |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 38 Years |
| Location | 405 Londonderry Dr, Waco, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285723882 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | H1978 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Health Center | Waco, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid Tex Anesthesia Assoc | 5395815369 | 24 |
News Archive
Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved TWYNSTA®, a new highly effective single pill combination therapy of telmisartan (an angiotensin receptor blocker [ARB]) and amlodipine (a calcium-channel blocker [CCB]). TWYNSTA® is indicated for the treatment of hypertension, alone or with other antihypertensive agents, and as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.
A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis has begun.
The March of Dimes is calling for a nationwide effort to reduce U.S. preterm births to 5.5 percent of all live births by 2030. Seven other developed countries already have preterm birth rates below 6 percent, and 15 have rates below 7 percent.
News outlets covered Friday's vote in the House of Representatives to keep the IRS from enforcing parts of the Affordable Care Act and today's weekly GOP address by Sen. Susan Collins, R-Maine.
› Verified 5 days ago
| Entity Name | Mid Tex Anesthesia Assoc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174612857 PECOS PAC ID: 5395815369 Enrollment ID: O20080603000130 |
News Archive
Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved TWYNSTA®, a new highly effective single pill combination therapy of telmisartan (an angiotensin receptor blocker [ARB]) and amlodipine (a calcium-channel blocker [CCB]). TWYNSTA® is indicated for the treatment of hypertension, alone or with other antihypertensive agents, and as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.
A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis has begun.
The March of Dimes is calling for a nationwide effort to reduce U.S. preterm births to 5.5 percent of all live births by 2030. Seven other developed countries already have preterm birth rates below 6 percent, and 15 have rates below 7 percent.
News outlets covered Friday's vote in the House of Representatives to keep the IRS from enforcing parts of the Affordable Care Act and today's weekly GOP address by Sen. Susan Collins, R-Maine.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin F Lagrone, MD Po Box 224137, Dallas, TX 75222-4137 Ph: (254) 776-0266 | Benjamin F Lagrone, MD 405 Londonderry Dr, Suite 105, Waco, TX 76712-7924 Ph: (254) 776-0266 |
News Archive
Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved TWYNSTA®, a new highly effective single pill combination therapy of telmisartan (an angiotensin receptor blocker [ARB]) and amlodipine (a calcium-channel blocker [CCB]). TWYNSTA® is indicated for the treatment of hypertension, alone or with other antihypertensive agents, and as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.
A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis has begun.
The March of Dimes is calling for a nationwide effort to reduce U.S. preterm births to 5.5 percent of all live births by 2030. Seven other developed countries already have preterm birth rates below 6 percent, and 15 have rates below 7 percent.
News outlets covered Friday's vote in the House of Representatives to keep the IRS from enforcing parts of the Affordable Care Act and today's weekly GOP address by Sen. Susan Collins, R-Maine.
› Verified 5 days ago
Thomas J Valigura, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 Fax: 254-202-5849 | |
Stephanie Kemp, D.O Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 | |
Kyle Sulak, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 405 Londonderry Dr Ste 105, Waco, TX 76712 Phone: 254-776-0266 | |
Dr. Rachel Backstrom, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 | |
Thomas M White, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 405 Londonderry Dr, Suite 105, Waco, TX 76712 Phone: 254-776-0266 Fax: 254-776-2511 | |
Holly W Davis, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 405 Londonderry Dr, Suite 105, Waco, TX 76712 Phone: 254-776-0266 Fax: 254-776-2511 | |
Casey D Hector, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 405 Londonderry Dr, Suite 105, Waco, TX 76712 Phone: 254-776-0266 Fax: 254-776-2511 |